Grandperspective closes Series A financing of EUR 7 million together with Saudi Aramco Energy Ventures and existing investors 

October 17, 2022

Berlin/Kleinmachnow, Oktober 17th 2022 – Grandperspective, the German based company with the world’s first holistic emission monitoring system has successfully closed its Series A led by Saudi Aramco Energy Ventures (SAEV) together with the existing investors High-Tech Gründerfonds, Brandenburg Kapital and kineo finance. 

The funding will be used to support the worldwide commercialization of Grandperspective’s scanfeld® system and for the development of new software applications. With its unique software, scanfeld@ already offers early warning in case of hazardous emissions. In addition, the system will provide features for plant maintenance and ESG reporting. 

SAEV is known for its great expertise in scaling industrial innovations. We see a unique chance for setting a new standard of emission monitoring in this joint effort. Together we can demonstrate how the autonomous monitoring of industrial plants provides safety and contributes to the achievement of the sustainability goals. We provide continuous knowledge about all emissions of the chemical and petrochemical plant to empower our customers and facilitate change. Because in the end, what you don’t measure you don’t manage.

René Braun, CEO of Grandperspective, highlights the visionary potential of the new partnership

For Aramco Ventures, this investment in Grandperspective via our SAEV fund is very strategic.  The application of the Grandperspective technology has the potential to provide many safety, economic and operational benefits across our facilities.

Mahdi Aladel, CEO of Aramco Ventures

We at kineo capital are proud to continue our support of Grandperspective with equity as well as tailored debt financing. We are sure that the Grandperspective solution is increasingly relevant. It provides a very high level of safety on industrial production through the early detection of gas leaks and, in addition, can support a predictive maintenance schedule based on the monitoring data sets which will lower the overall risk and costs of running such a site.

Kreske Nickelsen, partner of kineo capital

For Brandenburg the investment with SAEV and other important investors illustrates the importance as an actual location of High-Tech-companies. Grandperspective will have a world-wide impact on safety-engineering for chemicals and process industry.

Thilo Neu, senior investment manager of Brandenburg Kapital

The remote monitoring solution developed by Grandperspective sets new standards by offering an unmatched fast and precise localization of gas leaks. The successful financing round demonstrates the excellent work of the team around the founders René Braun, Peter Maas and Alexander Herrmann and paves the way for further scaling.

Dr. Gernot Berger, senior investment Manager at High-Tech Gründerfonds. 

Foto: Grandperspective

About Saudi Aramco Energy Ventures (SAEV)
SAEV is the corporate venturing program of Aramco Ventures, a subsidiary of Aramco, the world’s leading integrated energy and chemicals company.   Its mission is ‘to invest globally into start-up and high growth companies with technologies of strategic importance to Aramco.  For more information, visit 

About Grandperspective GmbH (GP)
Grandperspective has developed the world’s first early warning system called scanfeld®. With scanfeld® based on FTIR spectroscopy, hundreds of different gases are located, identified and quantified from a distance of up to one kilometer. With just a few scanfeld® sensor units, even large areas, warehouses and production facilities can be monitored in this way. Gas leaks are quickly detected and the formation of dangerous gas clouds is tracked, measured and visualized in real time. 

About Brandenburg Kapital/ILB
Brandenburg Kapital GmbH is a subsidiary of the Investitionsbank des Landes Brandenburg (ILB). Since 1993, as the venture capital arm of ILB, it has supported Brandenburg-based companies by acquiring equity stakes and equity-like investments. As a public venture capital company, experienced lead investor and active partner, Brandenburg Kapital ensures a strong equity base for start-ups and small and medium-sized enterprises in the State of Brandenburg on the basis of a stable group environment. The Early-stage and Growth Fund is currently available in the amount of around 100 million euros for this purpose. The funds for the Brandenburg Kapital fund, which was set up on behalf of the Brandenburg Ministry of Economics, are currently provided by the European Fund for Regional Development and by the ILB. Through ILB’s investment activities, 244 companies have so far been supported on their growth course with around 275 million euros. In addition, private investors have invested more than 600 million euros in the companies to date. For more information:  

About High-Tech Gründerfonds
The seed investor High-Tech Gründerfonds (HTGF) finances tech start-ups with growth potential and has supported over 680 start-ups since 2005. With the launch of its fourth fund, HTGF now has over 1.3 billion euros under management. Its team of experienced investment managers and start-up experts support young companies with expertise, entrepreneurial spirit and passion. HTGF’s focus is on high-tech start-ups in the fields of digital tech, industrial tech, life sciences, chemistry and related business areas. To date, external investors have injected more than 4 billion euros of capital into the HTGF portfolio via more than 1,900 follow-on financing rounds. In addition, HTGF has already successfully sold shares in more than 160 companies. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and the Fraunhofer-Gesellschaft along with over 40 companies from a wide range of industries.

Press Contact
High-Tech Gründerfonds Management GmbH
Stefanie Grüter, Partner Communications & Relations
T.: +49 228 82300 188

Investor Contact
High-Tech Gründerfonds Management GmbH
Dr. Gernot Berger, Senior Investment Manager
T.: +49 228 82300 139

Stay up to date

Subscribe now and receive the latest press releases on investments and other news from High-Tech Gründerfonds. We inform you about important developments at HTGF and provide you with interesting news from our portfolio. Whether it’s a successful exit, a new exciting investment or HR news – you’ll be the first to know!

More Press posts

23. May 2023

smartbax Announces Seed Financing of €1.2 Million to Develop Next-generation Antibiotics

Munich, Germany, May 23, 2023 – smartbax, a biotech company developing next-generation antibiotics against multi-drug resistant bacteria, today announced the close of its seed financing round of €1.2 million from Boehringer Ingelheim Venture Fund (BIVF) and High-Tech Gründerfonds (HTGF), bringing smartbax’s total capital raised to €1.9 million. The funds will be used to advance smartbax’s small molecule antibiotics through preclinical studies, expand the company’s scientific tea
15. May 2023

Using an app to combat skin conditions: Nia Health receives millions in funding

The Berlin-based health tech start-up Nia Health receives 3.5 million euros in a seed financing round. The company originates from the Charité Universitätsmedizin Berlin and operates leading dermatology apps, including "Nia," the most widely downloaded app for people with atopic dermatitis. The company has a network of renowned cooperation partners consisting of pharmaceutical companies, health insurance companies and clinics. The great potential lies above all in Nia Health's ex
Dualyx Logo
15. May 2023

Dualyx raises €40 million to progress Treg therapies for autoimmune diseases into the clinic

Use of proceeds will enable the development of the Company’s lead autoimmune program DT-001, targeting TNFR2, as well as its pipeline of Treg candidates Financing co-led by Fountain Healthcare Partners, Forbion and Andera Partners with support from existing investors Bernard Coulie appointed as Independent Chairman with immediate effect May 15, 2023, Ghent, Belgium – Dualyx NV, a Ghent based biotech developing next generation immune modulators, today announces that it has